Abstract:The ribosomal origin of thiopeptide antibiotics, a class of sulfur-rich and highly modified poly(thi)azolyl natural products, has recently been uncovered and features complex post-translational modifications (PTMs) of a precursor peptide. Based on molecular engineering and production improvement, we report insight into the biosynthesis of two bicyclic thiopeptide compounds, thiostrepton and nosiheptide. The PTMs of thiostrepton tolerate variations in the first two amino acids of the core peptide part of the precursor peptide: (1) the mutation of Ile1 to Val had no apparent effect on molecular maturation, suggesting that attachment of the quinaldic moiety at position 1 is not residue-dependent for the construction of the side ring system; and (2) the change of Ala2 to Ser led exclusively to the production of an analog that bears a corresponding dehydroamino acid residue, indicating that dehydration at position 2 is site-selective or that the oxazoline formed by cyclodehydration is inaccessible for maturation. For nosiheptide biosynthesis in particular, we provide the first structural evidence that construction of the specific side ring system precedes formation of the common central heterocycle domain and therefore propose that formation of a characteristic thiopeptide framework interweaves both common and specific PTMs that are interdependent. The above efforts benefited from the development of a uniform approach to examine the effectiveness for trans expression of gene encoding precursor peptides and associated PTM capacity. This approach is independent of knowledge regarding organism-specific regulatory mechanisms and potentially applicable to other systems that produce ribosomally synthesized peptide natural products.

Discovery and Biosynthesis of Thioviridamide-Like Compounds

Discovery and Efficient Synthesis of a Biologically Active Alkaloid Inspired by Thiostrepton Biosynthesis

Opportunities and Challenges from Current Investigations into the Biosynthetic Logic of Nosiheptide-Represented Thiopeptide Antibiotics

Lanthipeptide Synthetases Participate the Biosynthesis of 2-Aminovinyl-cysteine Motifs in Thioamitides

Enzymatic Formation of an Aminovinyl Cysteine Residue in Ribosomal Peptide Natural Products

Formation of an Aminovinyl-Cysteine Residue in Thioviridamide Non-Lanthipeptides Occurs Through a Path Independent of Known Lanthionine Synthetase Activity in Streptomyces Sp. NRRL S-87

Synthesis, Anti-TMV Activities, and Action Mechanisms of a Novel Cytidine Peptide Compound

The Utilization of Lanthipeptide Synthetases is a General Strategy for the Biosynthesis of 2‐aminovinyl‐cysteine Motifs in Thioamitides**

Thiopeptide Biosynthesis Featuring Ribosomally Synthesized Precursor Peptides and Conserved Posttranslational Modifications

Biochemical Reconstitution Reveals the Biosynthetic Timing and Substrate Specificity for Thioamitides

Biosynthesis of Thiopeptide Antibiotics and Their Pathway Engineering

Synthesis, Structural Modification, and Biological Activity of a Novel Bisindole Alkaloid Iheymine A

Discovery of daspyromycins A and B, 2-aminovinyl-cysteine containing lanthipeptides, through a genomics-based approach

Convergent evolution of the Cys decarboxylases involved in aminovinyl-cysteine (AviCys) biosynthesis.

Synthesis, structural modification, and biological activity of a novel bisindole alkaloid iheyamine A

Recent Advances in Discovery, Bioengineering, and Bioactivity-Evaluation of Ribosomally Synthesized and Post-translationally Modified Peptides

Total Syntheses and Biological Activities of Vinylamycin Analogues.

Synthetic Compounds with 2-Amino-1,3,4-Thiadiazole Moiety Against Viral Infections

Synthesis and Anticancer Activity Assessment of Zelkovamycin Analogues

Recent Advances on Cyclodepsipeptides: Biologically Active Compounds for Drug Research

Insight into Bicyclic Thiopeptide Biosynthesis Benefited from Development of a Uniform Approach for Molecular Engineering and Production Improvement